Itron (NASDAQ:ITRI) Price Target Lowered to $82.00 at Oppenheimer

Itron (NASDAQ:ITRI) had its target price reduced by Oppenheimer from $90.00 to $82.00 in a report released on Friday morning, The Fly reports. They currently have an outperform rating on the scientific and technical instruments company’s stock. Oppenheimer also issued estimates for Itron’s Q3 2020 earnings at $0.44 EPS.

A number of other equities analysts have also recently commented on ITRI. Johnson Rice initiated coverage on Itron in a report on Tuesday, May 26th. They set a buy rating and a $80.00 price target for the company. BidaskClub raised Itron from a sell rating to a hold rating in a report on Friday, April 24th. Cowen lowered their price target on Itron from $88.50 to $78.00 and set an outperform rating for the company in a report on Tuesday, May 5th. Argus cut Itron from a buy rating to a hold rating in a report on Thursday, March 19th. Finally, JMP Securities lowered their target price on Itron from $95.00 to $80.00 and set a market outperform rating for the company in a report on Tuesday, May 5th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and nine have issued a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus price target of $80.78.

Shares of NASDAQ ITRI opened at $62.05 on Friday. The stock has a market capitalization of $2.49 billion, a PE ratio of 41.93, a P/E/G ratio of 1.42 and a beta of 1.34. The company has a debt-to-equity ratio of 1.75, a current ratio of 2.08 and a quick ratio of 1.75. The business has a fifty day moving average price of $64.62 and a two-hundred day moving average price of $71.73. Itron has a fifty-two week low of $40.48 and a fifty-two week high of $88.32.

Itron (NASDAQ:ITRI) last announced its quarterly earnings data on Monday, May 4th. The scientific and technical instruments company reported $0.57 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.56 by $0.01. Itron had a return on equity of 16.47% and a net margin of 2.40%. The firm had revenue of $598.40 million during the quarter, compared to analysts’ expectations of $614.83 million. During the same period in the previous year, the firm earned $0.70 EPS. The company’s quarterly revenue was down 2.6% compared to the same quarter last year. On average, equities analysts expect that Itron will post 1.75 EPS for the current year.

In other Itron news, CFO Joan S. Hooper sold 485 shares of the company’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $67.70, for a total value of $32,834.50. Following the sale, the chief financial officer now owns 30,257 shares in the company, valued at approximately $2,048,398.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Thomas S. Glanville sold 1,000 shares of the company’s stock in a transaction dated Tuesday, June 16th. The shares were sold at an average price of $70.07, for a total value of $70,070.00. Insiders sold a total of 5,365 shares of company stock worth $355,565 in the last quarter. Corporate insiders own 1.72% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ITRI. Norges Bank bought a new stake in shares of Itron in the 4th quarter valued at about $32,984,000. Victory Capital Management Inc. grew its position in shares of Itron by 112.3% in the 4th quarter. Victory Capital Management Inc. now owns 720,013 shares of the scientific and technical instruments company’s stock valued at $60,445,000 after buying an additional 380,798 shares during the last quarter. Rothschild & Co. Asset Management US Inc. bought a new stake in shares of Itron in the 4th quarter valued at about $30,716,000. Impax Asset Management Group plc grew its position in shares of Itron by 14.2% in the 1st quarter. Impax Asset Management Group plc now owns 2,211,024 shares of the scientific and technical instruments company’s stock valued at $123,028,000 after buying an additional 274,466 shares during the last quarter. Finally, Janus Henderson Group PLC boosted its position in shares of Itron by 22.2% during the 4th quarter. Janus Henderson Group PLC now owns 1,189,386 shares of the scientific and technical instruments company’s stock valued at $99,849,000 after purchasing an additional 215,863 shares in the last quarter. Hedge funds and other institutional investors own 93.88% of the company’s stock.

Itron Company Profile

Itron, Inc, a technology and service company, provides end-to-end solutions that measures, manages, and analyzes energy and water use worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.

Featured Article: Understanding the Price to Earnings Ratio (PE)

The Fly

Analyst Recommendations for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.